Literature DB >> 35615079

Automation of On-Resin Enrichment of S-Nitrosylated Proteins for Oxidized Cysteine-Selective cPILOT.

Andrew D Pumford, Albert B Arul, Katarena I Ford, Renã A S Robinson.   

Abstract

S-Nitrosylation (SNO) is a cysteine post-translational modification that increases with normal aging and is present in Alzheimer's disease and other aging-related illnesses. Detection of SNO-modified proteins can be challenging; however, we previously developed a robust quantitative proteomics approach termed "Oxidized Cysteine-Selective combined precursor isobaric labeling and isobaric tagging (OxcyscPILOT)" that allows for detection of endogenous SNO-modified proteins. OxcyscPILOT involves enrichment of SNO-modified proteins using a thiol-based resin. This enrichment is performed manually, and wash steps with the resin require numerous stages and buffer reagents. The goal of this study is to transfer the manual protocol to an automated liquid handler system in order to reduce wash steps, increase sample throughput, and minimize experimental error. In order to accomplish this, we evaluated the Biomek i7 liquid handler automated workstation and a Positive Pressure ALP (PPA) apparatus to conduct automated on-resin enrichment. Our findings provide starting pressure conditions for the use of PPA in an automated OxcyscPILOT proteomics workflow that could be transferred to other robotic liquid handling systems.

Entities:  

Year:  2021        PMID: 35615079      PMCID: PMC9129232          DOI: 10.15695/vurj.v11i1.5096

Source DB:  PubMed          Journal:  Vanderbilt Undergrad Res J        ISSN: 1555-788X


  15 in total

1.  Site-specific analysis of protein S-acylation by resin-assisted capture.

Authors:  Michael T Forrester; Douglas T Hess; J Will Thompson; Rainbo Hultman; M Arthur Moseley; Jonathan S Stamler; Patrick J Casey
Journal:  J Lipid Res       Date:  2010-11-02       Impact factor: 5.922

2.  High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Analyst       Date:  2016-05-06       Impact factor: 4.616

3.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.

Authors:  S P Gygi; B Rist; S A Gerber; F Turecek; M H Gelb; R Aebersold
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

4.  Enhanced sample multiplexing for nitrotyrosine-modified proteins using combined precursor isotopic labeling and isobaric tagging.

Authors:  Renã A S Robinson; Adam R Evans
Journal:  Anal Chem       Date:  2012-05-07       Impact factor: 6.986

Review 5.  Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes.

Authors:  Jason M Held; Bradford W Gibson
Journal:  Mol Cell Proteomics       Date:  2011-12-08       Impact factor: 5.911

Review 6.  Chemical-proteomic strategies to investigate cysteine posttranslational modifications.

Authors:  Shalise M Couvertier; Yani Zhou; Eranthie Weerapana
Journal:  Biochim Biophys Acta       Date:  2014-10-05

Review 7.  Sample Multiplexing Strategies in Quantitative Proteomics.

Authors:  Albert B Arul; Renã A S Robinson
Journal:  Anal Chem       Date:  2018-12-18       Impact factor: 6.986

8.  Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment.

Authors:  Haixing Wang; Wei-Jun Qian; Mark H Chin; Vladislav A Petyuk; Richard C Barry; Tao Liu; Marina A Gritsenko; Heather M Mottaz; Ronald J Moore; David G Camp Ii; Arshad H Khan; Desmond J Smith; Richard D Smith
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

Review 9.  Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

Authors:  Renã A S Robinson; Bushra Amin; Paul C Guest
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  Protein S-nitrosylation in health and disease: a current perspective.

Authors:  Matthew W Foster; Douglas T Hess; Jonathan S Stamler
Journal:  Trends Mol Med       Date:  2009-08-31       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.